UBS Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-338,400
Closed -$71.8M 10343
2023
Q3
$71.8M Buy
338,400
+26,400
+8% +$5.27M 0.02% 634
2023
Q2
$60M Buy
+312,000
New +$62M 0.02% 726
2017
Q3
Sell
-35,200
Closed -$1.82M 8087
2017
Q2
$1.82M Buy
+35,200
New +$2.24M ﹤0.01% 3103
2016
Q1
Sell
-1,700
Closed -$76K 8331
2015
Q4
$76K Hold
1,700
﹤0.01% 5443
2015
Q3
$66K Hold
1,700
﹤0.01% 5576
2015
Q2
$82K Hold
1,700
﹤0.01% 5577
2015
Q1
$60K Sell
1,700
-2,000
-54% -$68.2K ﹤0.01% 5881
2014
Q4
$119K Buy
+3,700
New +$129K ﹤0.01% 5524

Other funds holding SGEN

UBS Group's SGEN Position: Q4 2023 in Review

UBS Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 64,453 shares — an estimated $13.7M sold.

UBS Group first reported a position in SGEN in Q4 2014 and held it in 36 quarters. The position peaked at $29.5M in Q4 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • UBS Group reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 64,453 Seagen Inc. Common Stock shares in Q4 2023, an estimated $13.7M.
  • UBS Group first reported a position in Seagen Inc. Common Stock in Q4 2014 and held it in 36 quarters.
  • UBS Group's Seagen Inc. Common Stock position peaked at $29.5M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.